TIDMAPH

RNS Number : 7944N

Alliance Pharma PLC

28 October 2016

 
                                                    28 October 2016 
 

ALLIANCE PHARMA PLC

("Alliance" or the "Company")

Share Options

Alliance Pharma plc (AIM: APH), the specialty pharmaceutical company, announces that on 27(th) October 2016 it awarded the following options over ordinary shares of the Company to certain Directors.

 
 Name            Position      Number      Exercise     Date of    Percentage 
                                of Share    price        vesting    of issued 
                                Options     per Share               ordinary 
                                Awarded                             share 
                                                                    capital 
--------------  ------------  ----------  -----------  ---------  ----------- 
                 Chief 
 Andrew           Financial                             October 
  Franklin        Officer      155,000     47.50         2018      0.033 
--------------  ------------  ----------  -----------  ---------  ----------- 
                 Chief 
 Andrew           Financial                             October 
  Franklin        Officer      400,000     47.50         2020      0.085 
--------------  ------------  ----------  -----------  ---------  ----------- 
                 Deputy 
                  Chief 
 Peter            Executive                             October 
  Butterfield     Officer      200,000     47.50         2018      0.042 
--------------  ------------  ----------  -----------  ---------  ----------- 
                 Deputy 
                  Chief 
 Peter            Executive                             October 
  Butterfield     Officer      1,000,000   47.50         2020      0.212 
--------------  ------------  ----------  -----------  ---------  ----------- 
 

The vesting of the awards that are scheduled to vest in October 2018 is subject to continued employment and the vesting of the awards that are scheduled to vest in October 2020 is subject to continued employment and the satisfaction of certain performance conditions.

For further information:

 
 Alliance Pharma plc                             + 44 (0) 1249 466966 
 John Dawson, Chief Executive 
  Andrew Franklin, Chief Financial 
  Officer 
 Sarah Robinson, Company Secretary 
 www.alliancepharma.co.uk 
                                                     + 44 (0) 20 7466 
 Buchanan                                                        5000 
 Mark Court / Sophie Cowles 
  / Jane Glover 
 
                                                     + 44 (0) 20 7260 
 Numis Securities Limited                                        1000 
 Nominated Adviser: Michael 
  Meade / Freddie Barnfield 
 Corporate Broking: James 
  Black / Toby Adcock 
 

Notes to editors:

About Alliance Pharma

Alliance, founded in 1998, is an international specialty pharmaceutical company based in Chippenham, Wiltshire, UK. The Company has sales in more than 100 countries worldwide via direct sales, joint ventures and a network of distributors. Alliance has a strong track record of acquiring the rights to established niche products and it currently owns or licenses the rights to approximately 90 pharmaceutical and consumer healthcare products. The Company continues to explore opportunities to expand its product portfolio.

Alliance joined the AIM market of the London Stock Exchange in December 2003 and trades under the symbol APH.

 
 1    Details of the person discharging managerial 
       responsibilities / person closely associated 
---  -------------------------------------------------------------------------- 
 a)   Name                       1. Andrew Franklin 2. Peter 
                                  Butterfield 
---  -------------------------  ----------------------------------------------- 
 2    Reason for the notification 
---  -------------------------------------------------------------------------- 
 a)   Position/status            1. Chief Financial Officer 
                                  2. Deputy Chief Executive 
                                  Officer 
---  -------------------------  ----------------------------------------------- 
 b)   Initial notification       Initial 
       /Amendment 
---  -------------------------  ----------------------------------------------- 
 3    Details of the issuer, emission allowance 
       market participant, auction platform, auctioneer 
       or auction monitor 
---  -------------------------------------------------------------------------- 
 a)   Name                       Alliance Pharma plc 
---  -------------------------  ----------------------------------------------- 
 b)   LEI                        n/a 
---  -------------------------  ----------------------------------------------- 
 4    Details of the transaction(s): section to 
       be repeated for (i) each type of instrument; 
       (ii) each type of transaction; (iii) each 
       date; and (iv) each place where transactions 
       have been conducted 
---  -------------------------------------------------------------------------- 
 a)   Description of             Options to subscribe for 
       the financial              new ordinary shares of 1p 
       instrument, type           each 
       of instrument 
                                  ISIN: GB0031030819 
       Identification 
       code 
---  -------------------------  ----------------------------------------------- 
 b)   Nature of the              Grant of options 
       transaction 
---  -------------------------  ----------------------------------------------- 
 c)   Price(s) and volume(s)      Exercise Price(s)   Volume(s) 
                                  ------------------  ------------------------- 
                                   1. 47.5p per                   1. 555,000 
                                    share 2. 47.5p                 2. 1,200,000 
                                    per share 
                                  ------------------  ------------------------- 
---  -------------------------  ----------------------------------------------- 
 d)   Aggregated information     Total 1,755,000 options granted 
                                  at a price of 47.5p per share 
 
       - Aggregated volume 
 
 
       - Price 
---  -------------------------  ----------------------------------------------- 
 e)   Date of the transaction    27 October 2016 
---  -------------------------  ----------------------------------------------- 
 f)   Place of the transaction   Outside of trading venue 
---  -------------------------  ----------------------------------------------- 
 

This information is provided by RNS

The company news service from the London Stock Exchange

END

DSHAKFDKABDDCKB

(END) Dow Jones Newswires

October 28, 2016 12:13 ET (16:13 GMT)

Alliance Pharma (LSE:APH)
Historical Stock Chart
From Feb 2024 to Mar 2024 Click Here for more Alliance Pharma Charts.
Alliance Pharma (LSE:APH)
Historical Stock Chart
From Mar 2023 to Mar 2024 Click Here for more Alliance Pharma Charts.